Your browser doesn't support javascript.
loading
Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance).
Magbanua, Mark Jesus M; Rugo, Hope S; Wolf, Denise M; Hauranieh, Louai; Roy, Ritu; Pendyala, Praveen; Sosa, Eduardo V; Scott, Janet H; Lee, Jin Sun; Pitcher, Brandelyn; Hyslop, Terry; Barry, William T; Isakoff, Steven J; Dickler, Maura; Van't Veer, Laura; Park, John W.
Afiliação
  • Magbanua MJM; Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California. mark.magbanua@ucsf.edu john.park@ucsf.edu.
  • Rugo HS; Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California.
  • Wolf DM; Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California.
  • Hauranieh L; Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California.
  • Roy R; Helen Diller Family Comprehensive Cancer Center and Computational Biology and Informatics, University of California at San Francisco, San Francisco, California.
  • Pendyala P; Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California.
  • Sosa EV; Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California.
  • Scott JH; Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California.
  • Lee JS; Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California.
  • Pitcher B; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Hyslop T; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Barry WT; Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Isakoff SJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Dickler M; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Van't Veer L; Department of Laboratory Medicine, University of California at San Francisco, San Francisco, California.
  • Park JW; Division of Hematology/Oncology, University of California at San Francisco, San Francisco, California. mark.magbanua@ucsf.edu john.park@ucsf.edu.
Clin Cancer Res ; 24(6): 1486-1499, 2018 03 15.
Article em En | MEDLINE | ID: mdl-29311117

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Perfilação da Expressão Gênica / Genômica / Células Neoplásicas Circulantes Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Perfilação da Expressão Gênica / Genômica / Células Neoplásicas Circulantes Idioma: En Ano de publicação: 2018 Tipo de documento: Article